Viewing Study NCT00045669


Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-01-01 @ 2:57 PM
Study NCT ID: NCT00045669
Status: COMPLETED
Last Update Posted: 2019-02-15
First Post: 2002-09-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
Sponsor: University Health Network, Toronto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module